Neighbourhood Disadvantage and 30-day Rehospitalization; Teixobactin – a Novel Antibiotic
Reena and Amol want you to understand the following:
1. Neighbourhood disadvantage was associated with an increased risk of readmission similar to the presence of chronic diseases like COPD.
2. Teixobactin is a new antibiotic with activity against gram positive organisms that was discovered using a new technique of growing soil-dwelling bacteria.
Continuing Medical Education
Internists can receive 0.5 hours of Continuing Medical Education credit for each podcast they listen to through the Canadian Society of Internal Medicine (MOC Category 1) and the American Medical Association (PRA Category 1). To receive CME credit for listening to this podcast, please click here to fill out our Evaluation and Impact Assessment Form.
The papers
AJ Kind et al. Neighbourhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study. Ann. Intern Med. 2014 Dec 2;161(11):765-74. (PubMed).
LL Ling et al. A new antibiotic kills pathogens without detectable resistance. Nature. 2015 Jan 7 (ePub). (PubMed).
Additional links
HL Beforouz et al. Rethinking the Social History. N Engl J Med 2014; 371:1277-1279.
D Raza, G Block, S ter Kulie. Office Interventions for Poverty. Ontario Medical Review. Oct 2013.
Determining neighbourhood SES: HIPxChange – Area Deprivation Index calculator and toolkit.
Good stuff
Universal healthcare: the affordable dream. Amartya Sen, The Guardian. Jan 6, 2015.
What’s really to blame for ER congestion? Andre Picard, The Globe and Mail. Jan 6, 2015.
